<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">We sought to quantify the external validity of the various ongoing trials to a middle-aged and elderly West-European population from the Rotterdam Study. Specifically, we were interested to quantify what proportion of this study population would be eligible to participate in these trials and how many of those eligible are from high-risk categories.</p>
